SCHEMBL4084303

SCHEMBL4084303

CNC(=O)c1cccc2sccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 2/20 0.54
MAPK10 P53779 1/20 0.45
MAPT P10636 3/20 0.45
POLB P06746 2/20 0.45
HPGD P15428 2/20 0.45
KDM4E B2RXH2 2/20 0.45
MEN1 O00255 1/20 0.45
NPC1 O15118 1/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPK1 P28482 1/20 0.45
RECQL P46063 1/20 0.45
RAB9A P51151 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
GAA P10253 1/20 0.44
MTNR1A P48039 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4085351 0.98 PLK1 (0.53) PLK1MAPK10MAPTPOLBHPGD
SCHEMBL827674 0.80 CNR2 (0.44) MAPTPOLBHPGDKDM4EALDH1A1
SCHEMBL826816 0.79 TSHR (0.46) MAPTPOLBHPGDKDM4EMEN1
SCHEMBL29599494 0.79 TSHR (0.46) MAPTPOLBHPGDKDM4EMEN1
SCHEMBL2083799 0.78 NR4A1 (0.48) HPGDKDM4EALDH1A1SMN1; SMN2HDAC3
SCHEMBL4083077 0.78 P2RX7 (0.51) MAPTHPGDKDM4EMEN1NPC1
SCHEMBL9690144 0.77 POLB (0.41) POLBHPGDKDM4EMEN1MAPK1
SCHEMBL12923812 0.77 HDAC3 (0.72) PLK1MAPTPOLBHPGDKDM4E
SCHEMBL827310 0.77 ALDH1A1 (0.47) MAPK10MAPTHPGDKDM4EMEN1
SCHEMBL30745208 0.77 ALDH1A1 (0.47) MAPK10MAPTHPGDKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7547691-B2 [4-(Benzo[B]thiophen-2-yl) Pyrimidin-2-yl]-amine derivatives as IKK-beta inhibitors for the treatment of cancer and inflammatory diseases ELI LILLY AND COMPANY (US) 2009-06-16 US disclosed
US-20080306082-A1 [4-(Benzo[B]Thiophen-2-Yl) Pyrimidin-2-Yl]-Amine Derivatives As Ikk-Beta Inhibitors For The Treatment Of Cancer And Inflammatory Diseases ELI LILLY AND COMPANY 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306082-A1 [4-(Benzo[B]Thiophen-2-Yl) Pyrimidin-2-Yl]-Amine Derivatives As Ikk-Beta Inhibitors For The Treatment Of Cancer And Inflammatory Diseases NFKBIA, IKBKB, IKBKG PLK1 394/4885MAPK10 754/4885MAPT 2245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.